Kang Wu
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology 11
- SARS-CoV-2 and COVID-19 Research 3
-
- Immune responses and vaccinations 4
- interferon and immune responses 3
-
- Cancer therapeutics and mechanisms 4
- RNA modifications and cancer 4
-
- Mycobacterium research and diagnosis 9
-
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Xiao‐Yong FanDouglas B. LowrieZhidong HuKristian Thestrup‐PedersenMarianne LundKaren BangSøren C. MogensenTung M. Fong
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Kang Wu
54 papers receiving 559 citations
Peers
Comparison fields: 5 of 99
- Infectious Diseases 136
- Endocrine and Autonomic Systems 42
- Immunology 116
- Cell Biology 89
- Molecular Biology 211
Countries citing papers authored by Kang Wu
This map shows the geographic impact of Kang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kang Wu more than expected).
Fields of papers citing papers by Kang Wu
This network shows the impact of papers produced by Kang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kang Wu. The network helps show where Kang Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kang Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 9 | |
| 6 | 2024 | 7 | |
| 7 | 2023 | 13 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 6 | |
| 10 | 2023 | 1 | |
| 11 | 2021 | 11 | |
| 12 | 2021 | 8 | |
| 13 | 2021 | 13 | |
| 14 | 2019 | 7 | |
| 15 | 2018 | 9 | |
| 16 | 2017 | 45 | |
| 17 | 2014 | 2 | |
| 18 | 2012 | 23 | |
| 19 | [The expression of recombinant protein of human interleukin-24 and its anti-tumor mechanism]. | 2005 | 1 |
| 20 | 2001 | 42 |
About Kang Wu
Kang Wu is a scholar working on Infectious Diseases, Hematology and Immunology, having authored 56 papers that have together received 568 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (9 papers), Multiple Myeloma Research and Treatments (5 papers), Immune responses and vaccinations (4 papers), Cancer therapeutics and mechanisms (4 papers), RNA modifications and cancer (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and interferon and immune responses (3 papers). The work is most often cited by research in Infectious Diseases (136 citations), Endocrine and Autonomic Systems (42 citations) and Immunology (116 citations). Kang Wu has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Xiao‐Yong Fan, Douglas B. Lowrie, Zhidong Hu, Kristian Thestrup‐Pedersen, Marianne Lund, Karen Bang, Søren C. Mogensen, Tung M. Fong, Lauren P. Shearman and L. H. T. Van der Ploeg. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.